Cargando…

Methotrexate-induced CD30(+) T-cell lymphoproliferative disorder of the oral cavity

Detalles Bibliográficos
Autores principales:	Saleh, Jamal Z., Lee, Linda H., Schieke, Stefan M., Hosking, Paul R., Hwang, Sam T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011174/ https://www.ncbi.nlm.nih.gov/pubmed/27626055 http://dx.doi.org/10.1016/j.jdcr.2016.02.002

Ejemplares similares

Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder
por: Ikeue, Tatsuyoshi, et al.
Publicado: (2019)

Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders
por: Gentile, Michelle S., et al.
Publicado: (2015)

Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features
por: Namiki, Takeshi, et al.
Publicado: (2018)

Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
por: Abdulla, Farah R., et al.
Publicado: (2021)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

Methotrexate-associated lymphoproliferative disorder with hypopituitarism and central diabetes insipidus
por: Aoshima, Misaki, et al.
Publicado: (2019)

Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis
por: Tanaka, Keisuke, et al.
Publicado: (2023)

Remittance of primary cutaneous CD30(+) lymphoproliferative disorder in a patient on adalimumab
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes
por: Ujino, Mariko, et al.
Publicado: (2019)

Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report
por: Toyonaga, Haruka, et al.
Publicado: (2019)

Methotrexate-related lymphoproliferative disorders in the liver: Case presentation and mini-review
por: Mizusawa, Takeshi, et al.
Publicado: (2019)

Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report
por: Dimassi, Ahmad B, et al.
Publicado: (2020)

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
por: Prieto-Torres, Lucia, et al.
Publicado: (2019)

Oral Lesions and Lymphoproliferative Disorders
por: Castellarin, P., et al.
Publicado: (2010)

Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder
por: Eso, Yuji, et al.
Publicado: (2018)

Lung cancer combined with methotrexate-associated lymphoproliferative disorder: A case report
por: Sekimura, Atsushi, et al.
Publicado: (2019)

Methotrexate-Associated Lymphoproliferative Disorder Developed Ectopically in the Maxillary Gingiva and Bilateral Lungs
por: Obata, Kyoichi, et al.
Publicado: (2020)

A case of ulcerative tuberculous cellulitis in the setting of methotrexate-associated lymphoproliferative disorder
por: Shigehara, Yohya, et al.
Publicado: (2022)

CD30+ Primary Cutaneous Post-transplant Lymphoproliferative Disorder with Signet-ring Cell Features
por: Malviya, Neeta, et al.
Publicado: (2016)

Methotrexate-Induced Lymphoproliferative Disorder Complicating Into Spontaneous Tumor Lysis Syndrome and Disseminated Intravascular Coagulation
por: Parajuli, Abinash, et al.
Publicado: (2023)

Methotrexate-associated lymphoproliferative disorder of the thoracic spine in a patient with rheumatoid arthritis receiving methotrexate: a case report
por: Kamio, Satoshi, et al.
Publicado: (2021)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
por: Twist, Clare J., et al.
Publicado: (2013)

(18)F‐FDG PET‐CT in a patient with methotrexate‐associated lymphoproliferative disorder
por: Shimizu, Hayato, et al.
Publicado: (2017)

Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma
por: Ishigaki, Sho, et al.
Publicado: (2018)

Methotrexate-associated Lymphoproliferative Disorder in the Liver Resembling Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Tsuruoka, Mio, et al.
Publicado: (2020)

Methotrexate-associated lymphoproliferative disorders in the central nervous system and stomach: A case report
por: Kawazoe, Mai, et al.
Publicado: (2020)

Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder
por: Sakaguchi, Ryuki, et al.
Publicado: (2019)

Recurrent Methotrexate-related Lymphoproliferative Disorder of the Lumbar Spine Origin: A Case Report
por: Okuwaki, Shun, et al.
Publicado: (2021)

Primary Hepatic Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders After Methotrexate Therapy
por: Hatayama, Yasuki, et al.
Publicado: (2023)

Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment
por: Saito, Shuntaro, et al.
Publicado: (2018)

Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation
por: Ikeda, Kazuki, et al.
Publicado: (2016)

Primary Central Nervous System T-cell Lymphoma as Methotrexate-associated Lymphoproliferative Disorders: Case Report
por: KAWANO, Hiroto, et al.
Publicado: (2021)

Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature
por: Afonso, Carolina, et al.
Publicado: (2022)

PD‐L1 expression is associated with the spontaneous regression of patients with methotrexate‐associated lymphoproliferative disorders
por: Gion, Yuka, et al.
Publicado: (2021)

COVID-19 Vaccine Pfizer-BioNTech: Recurrence of CD30-positive lymphoproliferative disorder: case report
Publicado: (2021)

Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder
por: Kadin, Marshall E., et al.
Publicado: (2020)

The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)
por: Watanabe, Shiro, et al.
Publicado: (2016)

Adult T-cell Leukemia/Lymphoma as a Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis
por: Takajo, Ichiro, et al.
Publicado: (2018)

The potential usefulness of sputum cytology in the conclusive diagnosis of methotrexate-associated lymphoproliferative disorders: A case report
por: Mizuguchi, Seiya, et al.
Publicado: (2019)

The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders
por: Tokuhira, Michihide, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fde80vl38lbks9b1avc5f27mqo